rs2257440
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BA1
The NM_003823.4(TNFRSF6B):c.147C>T(p.Cys49Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.242 in 1,608,974 control chromosomes in the GnomAD database, including 52,952 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003823.4 synonymous
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003823.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNFRSF6B | TSL:1 MANE Select | c.147C>T | p.Cys49Cys | synonymous | Exon 1 of 3 | ENSP00000359013.1 | O95407 | ||
| RTEL1-TNFRSF6B | TSL:5 | n.*1486C>T | non_coding_transcript_exon | Exon 33 of 35 | ENSP00000457428.1 | D6RA96 | |||
| RTEL1-TNFRSF6B | TSL:5 | n.*1486C>T | 3_prime_UTR | Exon 33 of 35 | ENSP00000457428.1 | D6RA96 |
Frequencies
GnomAD3 genomes AF: 0.194 AC: 29483AN: 152104Hom.: 3886 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.253 AC: 58764AN: 232054 AF XY: 0.252 show subpopulations
GnomAD4 exome AF: 0.247 AC: 360526AN: 1456752Hom.: 49069 Cov.: 33 AF XY: 0.248 AC XY: 179419AN XY: 724452 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.194 AC: 29482AN: 152222Hom.: 3883 Cov.: 34 AF XY: 0.196 AC XY: 14607AN XY: 74404 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.